Events for May 19, 2024

Our annual conference highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments. The drug repurposing field has shifted after stepping into the limelight during the COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognizing the opportunities to repurpose a drug to treat an often rare and neglected condition. Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines – the answers have been right under our noses all along!

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.